Articles by tag: autoimmune-disease

LAG-3 agonist IMP761: first clinical success in autoimmune diseases

LAG-3 agonist IMP761 has shown clinical efficacy in suppressing T-cells for the first time. Learn about the revolution in treating autoimmune diseases without side effects. Read more.

Saphnelo Pen approved by FDA: treating lupus at home

FDA approved Saphnelo subcutaneous pre-filled pens for lupus treatment. Patients can self-administer the drug without visiting a clinic. Learn about the breakthrough in therapy.